XENOGENEIC THYMIC TRANSPLANTATION AS AN ADJUNCT TO TREATMENT OF AIDS
XENOGENEIC THYMIC TRANSPLANTATION AS AN ADJUNCT TO TREATMENT OF AIDS
批准号:
6453752
负责人:
M ROSENZWEIG
金额:
$11.11万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2001
资助国家:
美国
项目状态:
已结题
起止时间:
2001-05-01 至 2002-04-30
中文摘要
点击翻译按钮获取中文摘要
英文摘要
The goal of this project is to determine the feasability of
xenogeneic pig thymus to engraft in an SIV infected macaque, and to
determine if this has any impact on T cell reconstitution The initial
aim was to establish baseline assays to determine the degree of
immunosupression as a result of SIV We have conducted comprehensive
analysis to determine the optimal in vitro conditions to determine
both alloantigen and xenoantigen responses in macaques Our data
demonstrate poor to absent xeno and allo- responses in macaques with
advanced SIV disease, as well as 1-2 log reduction in the
proliferation response to lectin Based on the poor in vitro
proliferative responses we wished to examine whether pig thymic tissue
might engraft in SIV-infected macaques without any conditioning We
therefore performed transplants of pig thymic tissue in 2 SIV-infected
macaques with advanced disease (CD4<200 mm3) Biopsy of the transplant
site at 30 days revealed lymphoid aggrega tes of rhesus T cells in
both animals, with only minimal inflammatory changes outside the
lymphoid aggregates No evidence for engraftment of pig thymic tissue
was observed (negative results for pig cytokeratin, MHC class I, MHC
class II, and CD2) These results suggest that even SIV-infected
animals with advanced disease are able to mount sufficient immune
responses to reject swine thymus Due to our inability to achieve
engraftment of pig thymus in SIV infected macaques in the absence of
conditioning (see below), we altered our experimental design to
include a conditioning protocol, namely cyclophosphamide
anti-thymocyte globulin (ATG) and cyclosporine In the first animal
examined, we achieved 99% depletion of peripheral T cells (CD3+)
following ATG treatment, but the CD3+ count rapidly returned to
baseline within 3 days The second animal received 3 additional days of
ATG, but we observed poor T cell depletion only (90%) depletion after
6 days of ATG Both animals received pig thymus in both the omentum and
quadriceps Antiretroviral therapy as well as PCP prophylaxis was
continued Biopsies of the quadriceps muscle transplant sites at 1 and
3 months demonstrated profound infiltration of rhesus CD3+CD8+ T cells
into the area, with no evidence for engraftment as detected by
immunohistochemistry for cytokeratin as well as pig-specific antigens
We concluded that we had a low level engraftment, but no clear
functional thymus was detected A clear problem in data interpretation
is that the animals both had detectable thymus in the mediastinum at
autopsy, so the rebound of naive T cells cannot be used as an
indicator of engraftment and function, this will be addressed by
performing thymectomy prior to SIV-infection in subsequent animals
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
ESTABLISHMENT OF RHESUS BONE MARROW CHIMERAS
-
批准号:6591322
-
项目类别:
-
资助金额:$11.11万
-
财政年份:2002
-
负责人:M ROSENZWEIG
-
依托单位:
STEM CELL GENE THERAPY USING LONG TERM BONE MARROW CULTURE TRANSDUCTION PROTOCOL
-
批准号:6591288
-
项目类别:
-
资助金额:$11.11万
-
财政年份:2002
-
负责人:M ROSENZWEIG
-
依托单位:
IN VIVO ANALYSIS OF T CELL TURNOVER IN RHESUS MACAQUES
-
批准号:6591317
-
项目类别:
-
资助金额:$11.11万
-
财政年份:2002
-
负责人:M ROSENZWEIG
-
依托单位:
EXPRESSION OF BCL 2 IN SIV INFECTED THYMIC TISSUE
-
批准号:6591316
-
项目类别:
-
资助金额:$11.11万
-
财政年份:2002
-
负责人:M ROSENZWEIG
-
依托单位:
FLT LIGAND PERIPHERAL BLOOD STEM CELL MOBILIZATION FOR STEM CELL GENE THERAPY
-
批准号:6591324
-
项目类别:
-
资助金额:$11.11万
-
财政年份:2002
-
负责人:M ROSENZWEIG
-
依托单位:
XENOGENEIC THYMIC TRANSPLANTATION AS AN ADJUNCT TO TREATMENT OF AIDS
-
批准号:6591306
-
项目类别:
-
资助金额:$11.11万
-
财政年份:2002
-
负责人:M ROSENZWEIG
-
依托单位:
EXPRESSION OF BCL 2 IN SIV INFECTED THYMIC TISSUE
-
批准号:6453762
-
项目类别:
-
资助金额:$11.11万
-
财政年份:2001
-
负责人:M ROSENZWEIG
-
依托单位:
IN VIVO ANALYSIS OF T CELL TURNOVER IN RHESUS MACAQUES
-
批准号:6453763
-
项目类别:
-
资助金额:$11.11万
-
财政年份:2001
-
负责人:M ROSENZWEIG
-
依托单位:
STEM CELL GENE THERAPY USING LONG TERM BONE MARROW CULTURE TRANSDUCTION PROTOCOL
-
批准号:6453734
-
项目类别:
-
资助金额:$11.11万
-
财政年份:2001
-
负责人:M ROSENZWEIG
-
依托单位:
ESTABLISHMENT OF RHESUS BONE MARROW CHIMERAS
-
批准号:6453768
-
项目类别:
-
资助金额:$11.11万
-
财政年份:2001
-
负责人:M ROSENZWEIG
-
依托单位:
FLT LIGAND PERIPHERAL BLOOD STEM CELL MOBILIZATION FOR STEM CELL GENE THERAPY
-
批准号:6453770
-
项目类别:
-
资助金额:$11.11万
-
财政年份:2001
-
负责人:M ROSENZWEIG
-
依托单位:
FLT LIGAND PERIPHERAL BLOOD STEM CELL MOBILIZATION FOR STEM CELL GENE THERAPY
-
批准号:6116549
-
项目类别:
-
资助金额:$12.84万
-
财政年份:1999
-
负责人:M ROSENZWEIG
-
依托单位:
IN VIVO ANALYSIS OF T CELL TURNOVER IN RHESUS MACAQUES
-
批准号:6116542
-
项目类别:
-
资助金额:$10.61万
-
财政年份:1999
-
负责人:M ROSENZWEIG
-
依托单位:
STEM CELL GENE THERAPY USING LONG TERM BONE MARROW CULTURE TRANSDUCTION PROTOCOL
-
批准号:6116551
-
项目类别:
-
资助金额:$12.84万
-
财政年份:1999
-
负责人:M ROSENZWEIG
-
依托单位:
EXPRESSION OF BCL 2 IN SIV INFECTED THYMIC TISSUE
-
批准号:6116541
-
项目类别:
-
资助金额:$10.61万
-
财政年份:1999
-
负责人:M ROSENZWEIG
-
依托单位:
XENOGENEIC THYMIC TRANSPLANTATION AS AN ADJUNCT TO TREATMENT OF AIDS
-
批准号:6116550
-
项目类别:
-
资助金额:$10.61万
-
财政年份:1999
-
负责人:M ROSENZWEIG
-
依托单位:
ESTABLISHMENT OF RHESUS BONE MARROW CHIMERAS
-
批准号:6116547
-
项目类别:
-
资助金额:$12.84万
-
财政年份:1999
-
负责人:M ROSENZWEIG
-
依托单位:
EXPRESSION OF BCL 2 IN SIV INFECTED THYMIC TISSUE
-
批准号:6313032
-
项目类别:
-
资助金额:$9.62万
-
财政年份:1978
-
负责人:M ROSENZWEIG
-
依托单位:
ESTABLISHMENT OF RHESUS BONE MARROW CHIMERAS
-
批准号:6313038
-
项目类别:
-
资助金额:$3.41万
-
财政年份:1978
-
负责人:M ROSENZWEIG
-
依托单位:
XENOGENEIC THYMIC TRANSPLANTATION AS AN ADJUNCT TO TREATMENT OF AIDS
-
批准号:6313022
-
项目类别:
-
资助金额:$9.62万
-
财政年份:1978
-
负责人:M ROSENZWEIG
-
依托单位:
海外基金